Key points are not available for this paper at this time.
Design
Review
Authors
No takes yet. Share an insight, caveat, or question.
M3-mAChR modulation may affect AF and ischemic outcomes; leaves open therapeutic targeting without prospective trials.
Wang et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: